Injury of muscle and tendon at neck level

ST19_INJURY_MUSCLE_TENDON_NECK_LEVEL

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — S16 Cause of death: ICD-10 — S16 2 out of 7 registries used, show all original rules.	67
4. Check minimum number of events None	67
5. Include endpoints None	67
6. Filter based on genotype QC (FinnGen only)	66

Control definitions (FinnGen only)

Control exclude: ST19_INJURI_NECK

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: S1
Name in latin: Laesio musculi/tendinis colli

NAME	ST19_INJURY_MUSCLE_TENDON_NECK_LEVEL
CONTROL_EXCLUDE	ST19_INJURI_NECK
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	S16
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	S16
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Injury of muscle and tendon at neck level based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	66	42	24
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	40.24	35.94	47.76

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
67: Matched controls
670

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

S16

ICD-10 Finland

Injury of muscle and tendon at neck level

+∞

92.8

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

85.6

21.5

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

25.8

8.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

213

2.21

2.57

3.4

9.6

1.22

mmol/l

0.15

184

(4200892) Spirometry reversibility

3.64

2.26

1.6

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2.28

2.02

3.1

3.2

45.55

32.70

ng/l

0.13

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

142

2.08

2.00

1.5

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3.77

1.88

6.0

40.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

244

1.91

1.80

5.8

5.9

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

2.89

1.79

2.0

2.6

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

4.06

1.74

1.4

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

2.49

1.64

1.2

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

120

1.95

1.57

1.3

1.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

0.00

1.57

0.0

2.5

—

81.74

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

2.77

1.56

1.4

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

183

1.80

1.45

1.6

2.0

—

(3012516) Albumin [Mass/volume] in Urine

115

1.91

1.45

3.1

3.2

4135.19

134.87

mg/l

0.46

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

509

2.04

1.31

11.5

10.3

94.21

91.11

ml/min/173m2

0.51

401

(3003694) ABO and Rh group [Type] in Blood

179

1.74

1.30

1.4

1.6

—

(3022217) INR in Platelet poor plasma by Coagulation assay

180

1.73

1.27

7.4

10.4

1.01

1.19

inr

2.68

(3020682) Albumin/Creatinine [Ratio] in Urine

122

1.78

1.19

3.8

3.7

10.35

16.33

mg/mmol

0.23

(40768804) Tissue Pathology biopsy report

201

1.68

1.19

2.2

1.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2.49

1.11

1.2

1.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

382

1.65

1.06

4.0

3.8

—

(3013115) Eosinophils [#/volume] in Blood

283

1.59

1.03

5.3

5.9

0.15

0.20

e9/l

1.86

252

(3019198) Lymphocytes [#/volume] in Blood

283

1.59

1.03

5.3

5.2

1.85

2.09

e9/l

0.55

256

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

0.00

1.00

0.0

2.2

—

0.75

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

0.00

1.00

0.0

2.2

—

1.54

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

165

1.60

0.95

3.3

2.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

509

1.80

0.90

3.9

3.8

5.88

5.66

mmol/l

0.49

476

(36304419) Bacteria [Presence] in Urine

141

1.60

0.88

2.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2.03

0.87

1.0

1.5

—

(3003338) MCHC [Mass/volume]

511

1.77

0.86

13.7

14.2

333.89

333.62

g/l

0.08

506

(3006315) Basophils [#/volume] in Blood

273

1.50

0.84

5.4

5.2

0.04

e9/l

0.02

243

(3001604) Monocytes [#/volume] in Blood

274

1.49

0.82

5.4

5.1

0.59

0.55

e9/l

0.39

244

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

0.00

0.81

0.0

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.80

0.0

1.7

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

163

1.52

0.78

3.3

3.6

11.82

19.83

ng/l

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1.94

0.76

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1.94

0.76

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1.94

0.76

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1.94

0.76

1.3

1.4

—

(3018095) Leukocytes [#/volume] in Urine

183

1.49

0.74

4.0

3.1

73.54

24.17

e6/l

0.44

125

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1.74

0.71

1.3

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

565

1.89

0.68

11.2

11.6

13.93

19.42

mg/l

1.16

428

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

466

1.52

0.66

4.0

3.7

—

(3013512) EKG study

115

1.51

0.64

2.8

3.3

—

(3042936) Bacteria identified in Isolate by Culture

1.66

0.62

1.4

2.8

—

(4034850) Laboratory test

0.00

0.61

0.0

6.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

0.00

0.61

0.0

4.8

—

4.97

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

0.00

0.61

0.0

2.1

—

24.18

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.00

0.61

0.0

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.00

0.61

0.0

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.00

0.61

0.0

1.2

—

(3002256) Pathology report gross observation

1.58

0.61

1.3

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.63

0.59

2.6

2.0

—

(3020891) Body temperature

0.00

0.59

0.0

2.7

—

(3019225) pH of Specimen

1.73

0.58

1.7

6.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.59

0.57

1.3

1.4

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1.55

0.57

1.3

2.6

2.39

2.42

g/l

—

(3041096) Erythrocytes [Presence] in Urine by Automated

164

1.41

0.56

3.3

2.6

—

(3023368) Bacteria identified in Blood by Culture

119

1.45

0.55

2.5

4.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

148

1.40

0.51

1.6

2.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1.62

0.51

1.4

4.0

216.29

224.69

u/l

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

125

0.68

0.49

1.1

2.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

254

1.33

0.48

1.9

2.9

—

(3021589) Normoblasts [#/volume] in Blood

255

0.74

0.47

8.7

8.2

0.00

e9/l

-0.00

208

(3026008) Bacteria identified in Urine by Culture

151

1.36

0.45

2.9

2.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.40

0.43

1.4

1.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.56

0.42

1.2

1.8

—

(3022621) pH of Urine by Test strip

1.56

0.42

1.8

1.9

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.42

0.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.42

0.0

1.1

—

(3037121) Protein [Mass/volume] in Urine

0.00

0.42

0.0

2.9

—

0.26

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.41

0.0

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.42

0.41

1.4

1.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

117

1.36

0.39

2.7

3.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

319

1.28

0.39

6.1

7.7

3.93

3.82

e9/l

0.14

282

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1.33

0.39

1.2

1.5

—

(40761511) CBC panel - Blood by Automated count

592

1.63

0.38

10.5

11.0

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1.47

0.37

3.7

2.4

1.77

1.71

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

0.67

0.36

1.5

1.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

214

1.27

0.35

3.9

3.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.37

0.35

1.7

—

(40761536) Microorganisms panel - Urine sediment

1.33

0.34

3.0

3.1

—

(3022145) Colonoscopy Study observation

1.42

0.33

2.0

1.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.25

0.26

2.3

1.7

—

(3008898) HLA-B27 [Presence]

1.38

0.24

1.2

1.0

—

(3044889) 12 lead EKG panel

341

1.19

0.23

3.1

3.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

536

1.27

0.23

3.9

3.5

1.50

1.45

mmol/l

0.35

502

(3002385) Erythrocyte distribution width [Ratio]

516

1.24

0.22

15.2

13.9

14.26

14.28

0.01

511

(1616796) Gas panel - Central venous blood

0.00

0.21

0.0

3.3

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.21

0.0

3.5

—

17.95

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

0.21

0.0

2.4

—

56.91

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

0.21

0.0

2.4

—

4.21

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

(3027315) Oxygen [Partial pressure] in Blood

0.00

0.21

0.0

3.9

—

8.08

—

(3013290) Carbon dioxide [Partial pressure] in Blood

0.00

0.21

0.0

3.9

—

4.80

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

0.21

0.0

3.7

—

(3009261) Glucose [Presence] in Urine by Test strip

274

1.17

0.20

4.0

3.1

0.00

estimate

—

(3022313) Gas panel - Capillary blood

0.00

0.20

0.0

5.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

0.00

0.20

0.0

2.3

—

3.82

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.19

0.20

1.5

1.4

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.19

0.20

7.5

6.2

104.50

103.76

mmol/l

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.19

0.20

2.7

1.5

—

(40758558) Short blood count panel - Blood

141

0.82

0.18

3.8

6.3

—

(36660697) Celiac disease serology panel - Serum

1.19

0.18

1.0

1.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1.13

0.16

2.8

4.1

0.82

0.83

mmol/l

—

(21494755) Public health laboratory ask at order entry panel

1.18

0.16

1.0

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

160

0.84

0.16

1.7

2.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

0.76

0.15

1.1

1.9

0.74

1.34

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

134

1.15

0.12

1.7

2.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

183

1.13

0.12

4.9

5.6

37.83

36.87

g/l

0.33

176

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

156

0.87

0.11

1.4

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

273

1.11

0.10

4.0

3.0

0.00

estimate

—

(1761868) Lipid panel - Serum or Plasma

205

1.11

0.09

2.5

—

(3029937) Albumin [Presence] in Urine by Test strip

146

1.13

0.09

5.1

3.3

0.00

estimate

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1.06

0.09

3.3

9.4

1.09

1.02

mmol/l

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

0.82

0.08

1.2

1.6

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

173

0.90

0.07

1.9

86.47

91.66

pmol/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

138

1.11

0.07

1.7

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

522

1.07

0.03

3.6

3.2

1.19

1.16

mmol/l

0.11

484

(3026493) Urate [Moles/volume] in Serum or Plasma

116

1.04

0.00

2.9

2.7

24434.83

337.22

umol/l

0.47

104

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

0.00

0.0

1.3

—

12.07

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3000494) Fungus identified in Specimen by Culture

0.85

0.00

1.0

1.8

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(40768806) Pleura Pathology biopsy report

0.00

-0.00

0.0

1.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

0.94

-0.00

3.6

3.5

602.33

763.30

ng/l

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.2

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

-0.00

0.0

1.0

—

(3024928) Oxygen saturation in Venous blood

0.00

-0.00

0.0

6.0

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

0.98

-0.00

2.6

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

0.00

-0.00

0.0

2.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

-0.00

0.0

1.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

18.3

—

1229.67

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

-0.00

0.0

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.2

—

3.96

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

-0.00

0.0

4.0

—

(3004809) Band form neutrophils/100 leukocytes in Blood

0.00

-0.00

0.0

3.4

—

3.00

—

(3011412) CD3 cells [#/volume] in Blood

0.00

-0.00

0.0

1.6

—

1.16

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

106.40

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.4

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

0.00

-0.00

0.0

1.6

—

0.12

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

-0.00

0.0

1.3

—

(3023420) DNA double strand Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.4

—

(3021901) Oxygen saturation in Capillary blood

0.00

-0.00

0.0

3.0

—

(3028626) Oxygen [Partial pressure] in Capillary blood

0.00

-0.00

0.0

2.7

—

8.54

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.2

—

106.78

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

-0.00

0.0

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.2

—

(3011648) Oxygen content in Venous blood

0.00

-0.00

0.0

3.4

—

11.62

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

0.00

-0.00

0.0

3.2

—

24.15

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

-0.00

0.0

2.9

—

71.26

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

-0.00

0.0

1.0

—

33.29

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

4.6

—

33.20

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.5

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

0.00

-0.00

0.0

1.6

—

590.00

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

0.00

-0.00

0.0

1.2

—

6.74

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

3.9

—

0.59

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

-0.00

0.0

1.7

—

88.78

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

-0.00

0.0

1.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.5

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

-0.00

0.0

3.0

—

104.40

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

2.6

—

(3028271) Lactate [Moles/volume] in Capillary blood

0.00

-0.00

0.0

2.0

—

1.46

—

(3000012) Reticulocyte production index

0.00

-0.00

0.0

1.0

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

0.00

-0.00

0.0

1.6

—

451.20

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

8.0

—

768.50

—

(40768797) Stomach Pathology biopsy report

0.98

-0.00

1.2

—

(3000492) Spirometry study

1.00

-0.00

1.7

1.3

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_INJURY_MUSCLE_TENDON_NECK_LEVEL – Injury of muscle and tendon at neck level

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Injury of muscle and tendon at neck level

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Injury of muscle and tendon at neck level (ST19_INJURY_MUSCLE_TENDON_NECK_LEVEL)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints